首页> 外文期刊>Experimental Neurology >Failure to detect cytotoxic T cell activity against recombinant Yo protein using autologous dendritic cells as the target in a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
【24h】

Failure to detect cytotoxic T cell activity against recombinant Yo protein using autologous dendritic cells as the target in a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.

机译:在患有副肿瘤性小脑变性和抗Yo抗体的患者中,未检测到以自体树突状细胞为靶标的针对重组Yo蛋白的细胞毒性T细胞活性。

获取原文
获取原文并翻译 | 示例
           

摘要

Paraneoplastic neurological syndromes are believed to be autoimmune neuronal degenerations that develop in some patients with systemic cancer. Although a high titer of anti-Yo antibody has been found in the sera and cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration (PCD), the role of anti-Yo antibody in Purkinje cell loss has not been shown. Previously we found that all of nine Japanese patients with PCD who harbored anti-Yo antibody had HLA A24. In this present study we have examined cytotoxic T cell (CTL) activity against recombinant Yo protein in peripheral blood of a patient with PCD and anti-Yo antibody using autologous dendritic cells as the target. We did not detect CTL activity against Yo protein, though, this study does not exclude the possibility of the involvement of CTL in the development of PCD. Copyright 1998 Academic Press.
机译:副肿瘤性神经系统综合症被认为是某些系统性癌症患者体内发生的自身免疫性神经元变性。尽管在副肿瘤性小脑变性(PCD)患者的血清和脑脊液中发现了高滴度的抗Yo抗体,但尚未显示出抗Yo抗体在浦肯野细胞丢失中的作用。以前,我们发现携带抗-Yo抗体的9名日本PCD患者全部患有HLA A24。在本研究中,我们检查了以自体树突状细胞为靶标的PCD和抗Yo抗体患者外周血中针对重组Yo蛋白的细胞毒性T细胞(CTL)活性。尽管我们没有检测到针对Yo蛋白的CTL活性,但这项研究并未排除CTL参与PCD发育的可能性。版权所有1998学术出版社。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号